Mirena Lawsuit News: Alleged Victims of Mirena Side Effects Claim Bayer Downplayed Risks Associated with IUD, Bernstein Liebhard LLP Reports

Share Article

The Firm is representing numerous Mirena IUD lawsuit clients who were allegedly harmed due to spontaneous migration of the IUD.

Free Case Review
Our Firm is representing numerous Mirena lawsuit clients who also claim Byer did not provide appropriate warnings about the risk of certain Mirena side effects.

Mirena lawsuits (http://www.themirenalawsuitcenter.com) continue to be filed in courts throughout the country on behalf of women who were allegedly harmed by the IUD, Bernstein Liebhard LLP reports. Most recently, a case was filed last month in the federal multidistrict litigation underway in U.S. District Court, Southern District of New York that alleges Bayer Healthcare Pharmaceuticals downplayed the risks associated with the contraceptive device. (Case No. 3:14-cv-00075-DRH-DGW)

“Our Firm is representing numerous Mirena lawsuit clients who also claim Bayer did not provide appropriate warnings about the risk of certain Mirena side effects,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free Mirena lawsuit evaluations to women who may have been injured due to the spontaneous migration of their IUD.

Mirena Lawsuit Allegations
According to court documents, more than 1,200 Mirena lawsuits have been filed in courts around the country on behalf of women who were allegedly injured due to spontaneous migration of the IUD. These include nearly 500 Mirena lawsuits that have been consolidated for pretrial proceedings in the U.S. District Court, Southern District of New York. (In re: Mirena IUD Products Liability Litigation, MDL No. 2434) An additional 700 lawsuits have been filed in New Jersey’s Bergen County Superior Court, where Bernstein Liebhard LLP is actively filing claims. (In Re: Mirena Litigation; Case No. 297)

Among other things, these lawsuits allege Bayer Healthcare Pharmaceuticals failed to provide adequate warnings regarding the possibility of Mirena migration, and point out that the IUD’s label only states that migration may occur if the uterus is punctured during insertion. The complaints also note that Bayer was cited by the U.S. Food & Drug Administration (FDA) in 2009 for a Mirena promotional campaign that the agency found to be misleading.

The Mirena IUD was approved by the FDA in 2000, and is now indicated as a method of contraception, and as a treatment for heavy menstrual bleeding in women who wish to use an IUD as their primary form of birth control. According to a report that aired on 7 Action News this past summer, the FDA has since received more than 70,000 complaints involving Mirena complications, including thousands that detail cases of device dislocation and uterine perforation.*

Compensation may be available to women who allegedly suffered uterine perforations and other Mirena side effects associated with spontaneous IUD migration. Find out more about the ongoing Mirena litigation by visiting Bernstein Liebhard LLP’s website, or the Firm’s Facebook page: https://www.facebook.com/mirenalawsuithelp. For a free legal consultation, please call 800-511-5092.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP represents the victims of defective drugs and medical devices on a contingency-fee basis, and our clients are never expected to pay attorneys fees unless their case results in a successful recovery on their behalf. New York State’s contingency fee cap rules generally limit those fees to 33 1/3% of the total recovery. As a result, the Firm’s fees can be significantly lower than those assessed by attorneys in other states, which depending on the law may amount to as much as 40% or more of a plaintiff’s recovery.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern
Visit website